@article{ARH3684,
author = {Simona Deidda and Francesco Cabras and Angelo Restivo},
title = {Aspirin: a new old anticancer drug},
journal = {Annals of Research Hospitals},
volume = {1},
number = {2},
year = {2017},
keywords = {},
abstract = {A positive effect of aspirin against colorectal cancer (CRC) was suggested for the first time by Kune et al. in 1988, who noticed a significant lower rate of aspirin users among new cases of colon and rectal cancer in Melbourne (Australia) metropolitan area [relative risk (RR), 0.49; 95% CI: 0.40–0.71] (1). Since then, the chemo-preventive potential of aspirin has been confirmed by different large cohort studies, in particular through analysis of data from large cardiovascular prevention trials (2).},
issn = {2523-0743}, url = {https://arh.amegroups.org/article/view/3684}
}